RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

It’s that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more sinister threat: RSV.

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

It often mimics the common cold, but RSV can quickly turn into bronchiolitis and pneumonia. “The older you get, the milder ...